Page last updated: 2024-08-22

trolamine salicylate and Cardiac Rupture, Post-Infarction

trolamine salicylate has been researched along with Cardiac Rupture, Post-Infarction in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fingleton, B	1

Reviews

1 review(s) available for trolamine salicylate and Cardiac Rupture, Post-Infarction

Article	Year
Matrix metalloproteinases as valid clinical targets. Current pharmaceutical design, 2007, Volume: 13, Issue:3 Topics: Animals; Arthritis; Atherosclerosis; Drug Design; Extracellular Matrix Proteins; Eye Diseases; Heart Rupture, Post-Infarction; Humans; Hypertrophy, Left Ventricular; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Myocardial Infarction; Neoplasms; Protease Inhibitors; Pulmonary Disease, Chronic Obstructive; Respiratory Distress Syndrome; Skin Diseases; Stroke; Vascular Diseases	2007

Article

Year

Matrix metalloproteinases as valid clinical targets.

Current pharmaceutical design, 2007, Volume: 13, Issue:3

Topics: Animals; Arthritis; Atherosclerosis; Drug Design; Extracellular Matrix Proteins; Eye Diseases; Heart Rupture, Post-Infarction; Humans; Hypertrophy, Left Ventricular; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Myocardial Infarction; Neoplasms; Protease Inhibitors; Pulmonary Disease, Chronic Obstructive; Respiratory Distress Syndrome; Skin Diseases; Stroke; Vascular Diseases

2007